Literature DB >> 20396861

Sustained expression of NADPH oxidase 4 by p38 MAPK-Akt signaling potentiates radiation-induced differentiation of lung fibroblasts.

Sarah Park1, Ji-Yeon Ahn, Min-Jin Lim, Mi-Hyoung Kim, Yeon-Sook Yun, Gajin Jeong, Jie-Young Song.   

Abstract

Radiation-induced fibrosis (RIF) is a long-term adverse effect of curative radiotherapy; however, the distinct molecular mechanisms of RIF in neighboring normal tissue are not fully understood. We investigated the mechanisms underlying radiation-induced fibroblast differentiation into myofibroblasts. Lung fibroblasts produced reactive oxygen species (ROS) immediately after irradiation, the level of which remained increased for 24 h. The NADPH oxidase inhibitor, diphenyleneiodonium (DPI), suppressed ROS production and significantly decreased the radiation-induced expression of alpha-smooth muscle actin (alpha-SMA) and fibronectin (FN). The mRNA and protein expression of Nox4 was increased by radiation, and siRNA knockdown of Nox4 reduced alpha-SMA and FN levels. Increased phosphorylation of p38MAPK, Erk, and PI3k/Akt was observed after irradiation. Inhibitors of p38 MAPK and Akt, but not of Erk, reduced radiation-induced fibroblast differentiation and Nox4 expression. Notably, DPI partially decreased phosphorylation of p38MAPK and Akt, suggesting that p38MAPK, Akt, and Nox4 may cooperate in a positive feedback loop. Nox4 expression was also increased during bleomycin-induced fibroblast differentiation, and downregulation of Nox4 reduced alpha-SMA levels and extracellular matrix (ECM) accumulation. These results demonstrate that interfering Nox4 activation can be a potential strategy to disrupt fibrotic process.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20396861     DOI: 10.1007/s00109-010-0622-5

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  35 in total

Review 1.  Molecular targets in pulmonary fibrosis: the myofibroblast in focus.

Authors:  Chris J Scotton; Rachel C Chambers
Journal:  Chest       Date:  2007-10       Impact factor: 9.410

2.  Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells.

Authors:  Martin Vejrazka; Radan Mícek; Stanislav Stípek
Journal:  Biochim Biophys Acta       Date:  2004-12-31

3.  Reactive oxygen species-mediated homologous downregulation of angiotensin II type 1 receptor mRNA by angiotensin II.

Authors:  T Ichiki; K Takeda; T Tokunou; Y Funakoshi; K Ito; N Iino; A Takeshita
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

4.  The NADPH oxidase inhibitor apocynin (acetovanillone) induces oxidative stress.

Authors:  Chiara Riganti; Costanzo Costamagna; Amalia Bosia; Dario Ghigo
Journal:  Toxicol Appl Pharmacol       Date:  2005-08-24       Impact factor: 4.219

5.  Fibrogenic signals in patients with radiation enteritis are associated with increased connective tissue growth factor expression.

Authors:  Marie Catherine Vozenin-Brotons; Fabien Milliat; Jean Christophe Sabourin; Anne Charlotte de Gouville; Agnès François; Philipe Lasser; Philipe Morice; Christine Haie-Meder; Antoine Lusinchi; Sami Antoun; Jean Bourhis; Denis Mathé; Theo Girinsky; Jocelyne Aigueperse
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-06-01       Impact factor: 7.038

6.  N-acetyl-L-cysteine inhibits TGF-beta1-induced profibrotic responses in fibroblasts.

Authors:  Hisatoshi Sugiura; Tomohiro Ichikawa; Xiangde Liu; Tetsu Kobayashi; Xing Qi Wang; Shin Kawasaki; Shinsaku Togo; Koichiro Kamio; Lijun Mao; Youngsoo Ann; Masakazu Ichinose; Stephen I Rennard
Journal:  Pulm Pharmacol Ther       Date:  2009-04-22       Impact factor: 3.410

7.  Superoxide radicals increase transforming growth factor-beta1 and collagen release from human lung fibroblasts via cellular influx through chloride channels.

Authors:  Shufan Qi; Gertjan J M den Hartog; Aalt Bast
Journal:  Toxicol Appl Pharmacol       Date:  2009-03-04       Impact factor: 4.219

8.  N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition.

Authors:  V M Felton; Z Borok; B C Willis
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-31       Impact factor: 5.464

9.  Soluble TGFbeta type II receptor gene therapy ameliorates acute radiation-induced pulmonary injury in rats.

Authors:  Zahid N Rabbani; Mitchell S Anscher; Xiuwu Zhang; Liguang Chen; Thaddeus V Samulski; Chuan-Yuan Li; Zeljko Vujaskovic
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-10-01       Impact factor: 7.038

Review 10.  [Diagnosis and therapy of interstitial lung diseases].

Authors:  C Neurohr; J Behr
Journal:  Dtsch Med Wochenschr       Date:  2009-03-03       Impact factor: 0.628

View more
  26 in total

Review 1.  NOX Modifiers-Just a Step Away from Application in the Therapy of Airway Inflammation?

Authors:  Joanna Wieczfinska; Milena Sokolowska; Rafal Pawliczak
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

2.  Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis.

Authors:  Jun Tashiro; Sharon J Elliot; David J Gerth; Xiaomei Xia; Simone Pereira-Simon; Rhea Choi; Paola Catanuto; Shahriar Shahzeidi; Rebecca L Toonkel; Rahil H Shah; Fadi El Salem; Marilyn K Glassberg
Journal:  Transl Res       Date:  2015-09-18       Impact factor: 7.012

3.  A Quantitative Proteomic Analysis of Urine from Gamma-Irradiated Non-Human Primates.

Authors:  Stephanie D Byrum; Marie S Burdine; Lisa Orr; Linley Moreland; Samuel G Mackintosh; Simon Authier; Mylene Pouliot; Martin Hauer-Jensen; Alan J Tackett
Journal:  J Proteomics Bioinform       Date:  2015-12-28

4.  RTP801 Amplifies Nicotinamide Adenine Dinucleotide Phosphate Oxidase-4-Dependent Oxidative Stress Induced by Cigarette Smoke.

Authors:  Daniel Hernández-Saavedra; Linda Sanders; Mario J Perez; Beata Kosmider; Lynelle P Smith; John D Mitchell; Toshinori Yoshida; Rubin M Tuder
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

5.  The Lactate Dehydrogenase Inhibitor Gossypol Inhibits Radiation-Induced Pulmonary Fibrosis.

Authors:  Jennifer L Judge; Shannon H Lacy; Wei-Yao Ku; Kristina M Owens; Eric Hernady; Thomas H Thatcher; Jacqueline P Williams; Richard P Phipps; Patricia J Sime; R Matthew Kottmann
Journal:  Radiat Res       Date:  2017-05-02       Impact factor: 2.841

6.  Regulation of acid-base transporters by reactive oxygen species following mitochondrial fragmentation.

Authors:  David Johnson; Erik Allman; Keith Nehrke
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-11       Impact factor: 4.249

7.  Inactivation of NADPH oxidases NOX4 and NOX5 protects human primary fibroblasts from ionizing radiation-induced DNA damage.

Authors:  Urbain Weyemi; Christophe E Redon; Towqir Aziz; Rohini Choudhuri; Daisuke Maeda; Palak R Parekh; Michael Y Bonner; Jack L Arbiser; William M Bonner
Journal:  Radiat Res       Date:  2015-02-23       Impact factor: 2.841

8.  Hypo-CpG methylation controls PTEN expression and cell apoptosis in irradiated lung.

Authors:  Xiuwu Zhang; Caroline Hadley; Isabel L Jackson; Yi Zhang; Angel Zhang; Ivan Spasojevic; Ines Batinic Haberle; Zeljko Vujaskovic
Journal:  Free Radic Res       Date:  2016-07-01

9.  The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rho kinase pathway.

Authors:  Ying Meng; Ting Li; Gao-Su Zhou; Yan Chen; Chang-Hui Yu; Miao-Xia Pang; Wei Li; Yang Li; Wen-Yong Zhang; Xu Li
Journal:  Antioxid Redox Signal       Date:  2014-10-02       Impact factor: 8.401

10.  Leukotriene B4 Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary Hypertension.

Authors:  Jin Qian; Wen Tian; Xinguo Jiang; Rasa Tamosiuniene; Yon K Sung; Eric M Shuffle; Allen B Tu; Antonia Valenzuela; Shirley Jiang; Roham T Zamanian; David F Fiorentino; Norbert F Voelkel; Marc Peters-Golden; Kurt R Stenmark; Lorinda Chung; Marlene Rabinovitch; Mark R Nicolls
Journal:  Hypertension       Date:  2015-10-05       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.